EA200300789A1 - Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи - Google Patents

Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи

Info

Publication number
EA200300789A1
EA200300789A1 EA200300789A EA200300789A EA200300789A1 EA 200300789 A1 EA200300789 A1 EA 200300789A1 EA 200300789 A EA200300789 A EA 200300789A EA 200300789 A EA200300789 A EA 200300789A EA 200300789 A1 EA200300789 A1 EA 200300789A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydroxy
ethanol
amino
treatment
urinary
Prior art date
Application number
EA200300789A
Other languages
English (en)
Inventor
Паскаль Пузе
Франц Эссер
Хисато Китагава
Наоки Ишигуро
Икунобу Мураматсу
Original Assignee
Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг filed Critical Берингер Ингельхайм Фарма Гмбх Унд Ко. Кг
Publication of EA200300789A1 publication Critical patent/EA200300789A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/31—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms
    • C07C311/35—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

В заявке описаны лекарственные средства, содержащие 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанол, один из двух его оптических изомеров и/или его фармакологически приемлемые соли, в частности, для лечения недержания мочи.Отчет о международном поиске был опубликован 2002.12.19.
EA200300789A 2001-02-01 2002-01-15 Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи EA200300789A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10104369A DE10104369A1 (de) 2001-02-01 2001-02-01 Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
PCT/EP2002/000311 WO2002060421A2 (en) 2001-02-01 2002-01-15 Use of 2-amino-1(4-hydroxy-2-methanesulphonamidophenyl)ethanol for treating urinary incontinence

Publications (1)

Publication Number Publication Date
EA200300789A1 true EA200300789A1 (ru) 2004-02-26

Family

ID=7672382

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300789A EA200300789A1 (ru) 2001-02-01 2002-01-15 Применение 2-амино-1-(4-гидрокси-3-метансульфонамидофенил)этанола для лечения недержания мочи

Country Status (26)

Country Link
EP (1) EP1363614B1 (ru)
JP (1) JP2004517158A (ru)
KR (1) KR20030075173A (ru)
CN (1) CN1489459A (ru)
AR (1) AR035778A1 (ru)
AT (1) ATE293966T1 (ru)
BG (1) BG108033A (ru)
BR (1) BR0206854A (ru)
CA (1) CA2434565A1 (ru)
CZ (1) CZ20032097A3 (ru)
DE (2) DE10104369A1 (ru)
DK (1) DK1363614T3 (ru)
EA (1) EA200300789A1 (ru)
EC (1) ECSP034684A (ru)
EE (1) EE200300357A (ru)
ES (1) ES2240708T3 (ru)
HU (1) HUP0302752A2 (ru)
IL (1) IL156730A0 (ru)
MX (1) MXPA03006816A (ru)
NO (1) NO20033428L (ru)
PL (1) PL361731A1 (ru)
PT (1) PT1363614E (ru)
SK (1) SK9772003A3 (ru)
UY (1) UY27145A1 (ru)
WO (1) WO2002060421A2 (ru)
ZA (1) ZA200305201B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10352132A1 (de) * 2003-11-04 2005-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Zusammensetzung aus einem Beta-3-Adrenozeptor-Agonisten und einem Alpha Agonisten
IL299897B2 (en) * 2013-08-19 2024-02-01 Taris Biomedical Llc Devices and methods for administering multiple units of drug

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US341584A (en) * 1886-05-11 Device foe
FR148F (ru) * 1962-01-24
HUT63827A (en) * 1990-02-07 1993-10-28 Nippon Shinyaku Co Ltd Process for producing sulfonanilide derivatives and pharmaceutical compositions comprising same
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
WO1996038143A1 (en) * 1995-06-02 1996-12-05 Synaptic Pharmaceutical Corporation The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
WO2000010557A1 (fr) * 1998-08-25 2000-03-02 Nippon Shinyaku Co.,Ltd. Preparations solides stabilisees

Also Published As

Publication number Publication date
ATE293966T1 (de) 2005-05-15
IL156730A0 (en) 2004-02-08
WO2002060421A2 (en) 2002-08-08
DK1363614T3 (da) 2005-05-30
NO20033428L (no) 2003-09-30
DE60203882D1 (de) 2005-06-02
CZ20032097A3 (cs) 2003-12-17
EE200300357A (et) 2003-10-15
JP2004517158A (ja) 2004-06-10
CN1489459A (zh) 2004-04-14
DE10104369A1 (de) 2002-08-08
AR035778A1 (es) 2004-07-14
BR0206854A (pt) 2004-01-13
EP1363614A2 (en) 2003-11-26
NO20033428D0 (no) 2003-07-31
CA2434565A1 (en) 2002-08-08
ES2240708T3 (es) 2005-10-16
HUP0302752A2 (hu) 2003-11-28
ZA200305201B (en) 2004-05-17
KR20030075173A (ko) 2003-09-22
ECSP034684A (es) 2003-08-29
PL361731A1 (en) 2004-10-04
SK9772003A3 (sk) 2005-03-04
WO2002060421A3 (en) 2002-12-19
BG108033A (en) 2004-12-30
MXPA03006816A (es) 2004-05-14
DE60203882T2 (de) 2006-02-02
PT1363614E (pt) 2005-06-30
EP1363614B1 (en) 2005-04-27
UY27145A1 (es) 2002-08-30

Similar Documents

Publication Publication Date Title
SE0100901D0 (sv) New composition
EA200300248A1 (ru) Бициклопиразолы, активные в качестве ингибиторов киназы, способ их получения и включающие их фармацевтические композиции
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
EA200200208A1 (ru) Синергитическая композиция
EA200300527A1 (ru) Новые способы лечения синдрома "усталых ног"
EA200300929A1 (ru) Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv
BR0207961A (pt) Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas
SV2002000245A (es) Oxazolidinonas substituidas y su uso ref. lea 34122-sv
LU91928I2 (fr) Ipilimumab et ses dérivés pharmaceutiquement acceptables (YERVOY®)
ECSP044992A (es) Inhibidores de la alquín-aril fosfodiesterasa-4
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP045081A (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
BR0314603A (pt) Uso de inibidores da sìntese de citoquina para o tratamento de distúrbios de olhos secos
SE9900100D0 (sv) New compounds
SE0101932D0 (sv) Pharmaceutical combinations
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
PT1228028E (pt) Sais de hidroxieicosatetraeniato, composicoes e metodos para utilizacao no tratamento de perturbacoes da secura ocular
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
SE0003476D0 (sv) Compounds
PT1268472E (pt) Inibidores 3-aminopirazolicos de cinases dependentes da ciclina
ATE287886T1 (de) Verwendung von 5-thio, sulfinyl- und sulfonylpyrazolo 3,4-b) pyridinen als cyclin- abhängige kinase-hemmer
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
IS6087A (is) N-(2-fenýl-4-amínó-bútýl)-1-naftamíð sem virka á móti taugakínín-1 viðtaka